Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 LG Electronics Inc LGLD Apr 25, 2025 12.30 +2.50   
 Life Science REIT Plc LABS Apr 25, 2025 44.80 0.00   
 LifeSafe Holdings Plc LIFS Apr 25, 2025 7.11 0.00   
 Light Science Technologies Holdings Plc LST Apr 25, 2025 3.99 +0.96   
 Likewise Group Plc LIKE Apr 25, 2025 18.85 +0.99   
 Lindsell Train Investment Trust LTI Apr 25, 2025 810.01 -1.48   
 Lion Finance Group Plc BGEO Apr 25, 2025 5 685.00 +0.09   
 Liontrust Asset Management plc LIO Apr 25, 2025 331.50 -1.78   
 Literacy Capital Plc BOOK Apr 25, 2025 370.00 0.00   
 Litigation Capital Management Limited LIT Apr 25, 2025 51.60 +0.78   
 Lloyds Banking Group PLC LLOY Apr 25, 2025 72.96 +0.05   
 LMS Capital Plc LMS Apr 25, 2025 23.20 +5.45   
 Logistics Development Group Plc LDG Apr 25, 2025 13.80 -1.43   
 London & Associate Properties plc LAS Apr 25, 2025 8.10 0.00   
 London Finance & Investment Group LFI Apr 25, 2025 105.00 +48.83   
 London Security plc LSC Apr 25, 2025 3 650.00 0.00   
 London Stock Exchange Group LSEG Apr 25, 2025 11 450.00 -1.34   
 LondonMetric Property Plc LMP Apr 25, 2025 191.90 +0.37   
 Lords Group Trading Plc LORD Apr 25, 2025 26.00 +1.96   
 Lowland Investment Co plc LWI Apr 25, 2025 128.00 +0.39   
 LPA Group plc LPA Apr 25, 2025 50.75 -6.02   
 LSL Property Services Plc LSL Apr 25, 2025 276.00 0.00   
 Luceco Plc LUCE Apr 25, 2025 131.60 +0.92   
 LungLife AI Inc LLAI Apr 25, 2025 2.20 -12.00   
 Lyxor Core MSCI Japan (DR) UCITS ETF LCJG Apr 25, 2025 19.23 +2.67   
 Lyxor Core STOXX Europe 600 (DR) - UCITS ETF Acc MEUD Apr 25, 2025 21 020.00 +0.33   
 Lyxor Core UK Government Bond (DR) UCITS ETF GILS Apr 25, 2025 10 183.00 +0.08   
 Lyxor Core US TIPS DR UCITS ETF TIPG Apr 25, 2025 8 583.00 +0.13   
 Lyxor MSCI EM Asia Ucits ETF LCAL Apr 25, 2025 8.71 +0.51   
 Lyxor Smart Overnight Return - ETF CSH2 Apr 25, 2025 117 987.00 +0.01   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.